Cargando…

PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG

Detalles Bibliográficos
Autores principales: Chang, H., He, G., Fu, R., Li, F., Han, B., Li, T., Liu, L., Mittal, H., Jin, H., Zhang, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431591/
http://dx.doi.org/10.1097/01.HS9.0000850632.68892.3e
_version_ 1784780096980123648
author Chang, H.
He, G.
Fu, R.
Li, F.
Han, B.
Li, T.
Liu, L.
Mittal, H.
Jin, H.
Zhang, F.
author_facet Chang, H.
He, G.
Fu, R.
Li, F.
Han, B.
Li, T.
Liu, L.
Mittal, H.
Jin, H.
Zhang, F.
author_sort Chang, H.
collection PubMed
description
format Online
Article
Text
id pubmed-9431591
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315912022-08-31 PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG Chang, H. He, G. Fu, R. Li, F. Han, B. Li, T. Liu, L. Mittal, H. Jin, H. Zhang, F. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431591/ http://dx.doi.org/10.1097/01.HS9.0000850632.68892.3e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Chang, H.
He, G.
Fu, R.
Li, F.
Han, B.
Li, T.
Liu, L.
Mittal, H.
Jin, H.
Zhang, F.
PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title_full PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title_fullStr PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title_full_unstemmed PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title_short PB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON-RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
title_sort pb1949: eltrombopag in chinese patients with refractory or relapsed severe aplastic anemia: a non-randomized, open-label, multicenter, phase ii study assessing the safety and efficacy of eltrombopag
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431591/
http://dx.doi.org/10.1097/01.HS9.0000850632.68892.3e
work_keys_str_mv AT changh pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT heg pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT fur pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT lif pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT hanb pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT lit pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT liul pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT mittalh pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT jinh pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag
AT zhangf pb1949eltrombopaginchinesepatientswithrefractoryorrelapsedsevereaplasticanemiaanonrandomizedopenlabelmulticenterphaseiistudyassessingthesafetyandefficacyofeltrombopag